Charles Nemeroff, an Emory University psychiatrist whose work has been highly influential and who has been at the center of a conflict-of-interest scandal, is moving to the University of Miami as its new psychiatry chair. Nemeroff resigned from the chair's position at Emory in December, amid growing Congressional scrutiny of payments he received from GlaxoSmithKline and did not report -- in violation of university rules, which are designed to ensure that federally supported research is not tainted by unknown financial conflicts of interest by researchers. The Miami Herald quoted Pascal Goldschmidt, dean of the University of Miami medical school, as acknowledging the controversy, but also calling Nemeroff "an extraordinary psychiatrist and scientist."
Inside Higher Ed’s Blog U
What Others Are Reading